About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pittsburgh | 10,700 Studies Near You

Clinical TrialsPittsburgh

Clinical Trials in Pittsburgh

Discover 10,700 clinical trials near Pittsburgh, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3141-3160 of 10,700 trials

CompletedA Pivotal Study of a Facet Replacement System to Treat Spinal StenosisThe purpose of this study is to determine if the ACADIA® Facet Replacement System is effective in the treatment of spinal stenosis.NCT00401518·Beverly Hills, California and 28 others TerminatedA Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial InfarctionThis is a double-blind, sham-controlled clinical study to evaluate the safety and feasibility of AMI MultiStem therapy in subjects who have had a heart attack (Non-ST elevation…NCT02277613·Birmingham, Alabama and 10 others

Find Trials by Condition in Pittsburgh

Breast Cancerin Pittsburgh Lung Cancerin Pittsburgh Prostate Cancerin Pittsburgh Colorectal Cancerin Pittsburgh Melanomain Pittsburgh Leukemiain Pittsburgh Lymphomain Pittsburgh Pancreatic Cancerin Pittsburgh Ovarian Cancerin Pittsburgh Brain Cancerin Pittsburgh

Data from ClinicalTrials.govTerms

CompletedChemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck CancerRATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells.NCT00047008·Birmingham, Alabama and 194 others

CompletedTo Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusThis is the first study in cutaneous lupus erythematosus subjects to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of CC-11050.NCT01300208·Rogers, Arkansas and 18 others

CompletedMAAT For Young Adult Cancer SurvivorsThe goal of this clinical trial is to pilot-test a modified version of telehealth-delivered Memory and Attention Adaption Training (MAAT) that is tailored to young adult childhood…NCT06150976·Indianapolis, Indiana and 2 others

CompletedPhase 3 Study of Dexpramipexole in ALSThe purpose of this study is to determine whether dexpramipexole (150 mg twice daily) is safe and effective in the treatment of Amyotrophic Lateral Sclerosis (ALS).NCT01281189·Phoenix, Arizona and 81 others

CompletedAcute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed ThrombolysisThe purpose of this study is to determine if the use of adjunctive Pharmacomechanical Catheter Directed Thrombolysis, which includes the intrathrombus administration of…NCT00790335·Glendale, Arizona and 55 others

TerminatedNatural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIBThe objectives of this study are to describe the clinical and biochemical characteristics and course of disease progression in participants with Mucopolysaccharidosis type IIIB…NCT02293408·Minneapolis, Minnesota and 6 others

CompletedSafety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.The purpose of this study is to determine the effect of two different doses of MCC-135, once daily (QD) or twice daily (BID), on the disease state and the quality of life in…NCT00050076·Phoenix, Arizona and 52 others

Approved for marketingExpanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)This clinical trial is being conducted in Hypophosphatasia, a bone disorder caused by gene mutation(s) resulting in bone defects.NCT02496689·Lakewood, Colorado and 4 others

CompletedMaribavir for Treatment of Resistant or Refractory CMV Infections in Transplant RecipientsThis study will assess safety, antiviral activity, and pharmacokinetics of different doses of maribavir administered orally for up to 24 weeks for treatment of CMV infections that…NCT01611974·Los Angeles, California and 31 others

CompletedPK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma PatientsThis is a study for the outcome and safety of individualized busulfan dosing with cyclophosphamide and etoposide for patients preparing for a stem cell transplant to treat…NCT00948090·Birmingham, Alabama and 41 others

CompletedDyslipidemia of Obesity Intervention in TeensThis trial of pitavastatin will determine efficacy and safety in this high risk population and provide evidence for clinicians to target this treatable risk factor to achieve an…NCT02956590·Wilmington, Delaware and 15 others

RecruitingTeaching Health Resilience in a Hospital Setting: A Peer-led InterventionThe purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting…NCT06843213·Pittsburgh, Pennsylvania and 2 others

CompletedOpen Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusThe primary objective of the study is assess the safety and tolerability of long-term epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)NCT01408576·Birmingham, Alabama and 227 others

CompletedPixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)The primary goal of this trial is to assess clinical response to nivolumab and pixatimod, and, nivolumab, pixatimod and cyclophosphamide in three separate patient cohorts.NCT05061017·Pittsburgh, Pennsylvania

CompletedIMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenThe purpose of this study is to show that abiraterone acetate plus prednisone added to the current standard of care, gonadotropin-releasing hormone (GnRH) decreases prostate…NCT01314118·Homewood, Alabama and 44 others

CompletedA Controlled Pregabalin Trial In FibromyalgiaTo evaluate the efficacy and safety of pregabalin compared with placebo for the relief of pain associated with fibromyalgia and improvement of function of patients with…NCT00230776·Little Rock, Arkansas and 88 others

CompletedToremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using toremifene may fight prostate cancer by reducing the production of androgens.NCT00020735·Pittsburgh, Pennsylvania

RecruitingBrain-Stomach Circuits in Chronic NauseaThe goal of this study is to determine whether stimulation of the brain-stomach connection can influence stomach activity in healthy adults and in individuals suffering from…NCT07276035·Pittsburgh, Pennsylvania

PreviousPage 158 of 535Next

Diabetes

in Pittsburgh

Heart Diseasein Pittsburgh